The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing small molecule anti-tumor therapeutics.

Total Raised

$70 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Therapeutics

Investment History

  1. Series B

    Mar 2018

    $70M

Team

Stephen Brady

Founder

Jennifer McDevitt

VP, Clinical Sciences

Stephen R. Brady

President & COO

Chan Whiting

SVP Reserch & Developement